Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Highlights
Retraction Note: HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation
Deng, Bixing Ye, Lei Lui, Yongchang Chen, Jun Du and Luo Gu agree with this retraction
Official journal of the Cell Death Differentiation Association
Summary
Retraction Note: HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation Shixiu Sun1,2, Yujie Zhang1,3, Jianchao Zheng1,4, Biao Duan1, Jie Cui5,6, Yan Chen6, Wenjie Deng1, Bixing Ye7, Lei Liu5,6, Yongchang Chen8, Jun Du 1,3 and Luo Gu1,3,6
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
